Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Acute Myeloid Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01798901
What this trial is testing

AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+7 more
Alison Walker 13
Large-scale testing (Phase 3)Study completedNCT00521664
What this trial is testing

A Trial Comparing a Prophylactic With a Therapeutic Platelet Transfusion Strategy in Two Groups

Who this might be right for
Myeloid Leukemia
Technische Universität Dresden 400
Testing effectiveness (Phase 2)Study completedNCT00274781
What this trial is testing

Arsenic Trioxide and Gemtuzumab Ozogamicin in Treating Patients With Advanced Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic Syndromes
The Cleveland Clinic 30
Large-scale testing (Phase 3)UnknownNCT04216771
What this trial is testing

Comparing the Consolidation Regimens of IDA With Intermediate-dose Cytarabine Versus Intermediate-dose Cytarabine Alone for Elderly AML Patients

Who this might be right for
AML in Remission
Fujian Medical University 320
Large-scale testing (Phase 3)UnknownNCT00002701
What this trial is testing

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia

Who this might be right for
Leukemia
European Organisation for Research and Treatment of Cancer - EORTC 750
Testing effectiveness (Phase 2)Ended earlyNCT01898793
What this trial is testing

Cytokine-induced Memory-like NK Cells in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Who this might be right for
Leukemia, Myeloid, Acute
Washington University School of Medicine 89
Early research (Phase 1)WithdrawnNCT03612739
What this trial is testing

EPITHINK: Epigenetic Drug Treatment and Therapeutic Immunotherapy With NKR-2

Who this might be right for
AML, AdultMyelodysplastic Syndromes
Celyad Oncology SA
Not applicableStudy completedNCT06181734
What this trial is testing

Ivosidenib (TIBSOVO®) Combined With Azacitidine According to Current SmPC

Who this might be right for
Acute Myeloid Leukemia (AML)
iOMEDICO AG 8
Large-scale testing (Phase 3)Study completedNCT00719563
What this trial is testing

American Ginseng in Treating Patients With Fatigue Caused by Cancer

Who this might be right for
Chronic Myeloproliferative DisordersFatigueLeukemia+7 more
Alliance for Clinical Trials in Oncology 364
Not applicableStudy completedNCT00112593
What this trial is testing

Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+176 more
Fred Hutchinson Cancer Center 5
Large-scale testing (Phase 3)Ended earlyNCT03616470
What this trial is testing

Study to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
GlycoMimetics Incorporated 388
Testing effectiveness (Phase 2)Looking for participantsNCT07607418
What this trial is testing

Ivosidenib as Maintenance Therapy in Transplant-Ineligible IDH1-mutated AML and HR-MDS

Who this might be right for
AML (Acute Myeloid Leukemia)MDS (Myelodysplastic Syndrome)
Ruijin Hospital 20
Early research (Phase 1)Study completedNCT00104923
What this trial is testing

Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+1 more
California Cancer Consortium 29
Large-scale testing (Phase 3)Looking for participantsNCT04293562
What this trial is testing

Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Who this might be right for
Acute Myeloid Leukemia
Children's Oncology Group 1,400
Testing effectiveness (Phase 2)Looking for participantsNCT06128070
What this trial is testing

Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome
City of Hope Medical Center 40
Early research (Phase 1)Study completedNCT01787474
What this trial is testing

Donor Natural Killer Cells in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Recurrent Adult Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00027560
What this trial is testing

Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Memorial Sloan Kettering Cancer Center 51
Testing effectiveness (Phase 2)Study completedNCT00235560
What this trial is testing

Rapamycin in Combination With Low-dose Aracytin in Elderly Acute Myeloid Leukemia Patients

Who this might be right for
Acute Myeloid Leukemia
University Hospital, Toulouse 50
Testing effectiveness (Phase 2)Study completedNCT02842827
What this trial is testing

Bomedemstat (IMG-7289/MK-3543) With and Without ATRA, in Participants With Advanced Myeloid Malignancies (IMG-7289-CTP-101/MK-3543-001)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) 45
Testing effectiveness (Phase 2)Ended earlyNCT01795924
What this trial is testing

Safety and Efficacy Study of PD-616 Plus Cytarabine to Treat Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
Biosuccess Biotech Co., Ltd. 13
Next Page